Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 40.1821.22112.252.74201.07

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is 40.18 based on Mar2023 Standalone results.
Year Core EBITDA Growth
Mar202340.18
Mar202221.22
Mar2021112.25
Mar20202.74
Mar2019201.07

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2023 40.18
89.35
Mar2022 21.22
-81.10
Mar2021 112.25
3,996.72
Mar2020 2.74
-98.64
Mar2019 201.07 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹857.7 Cr -3.3% 9.6% -3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹370,757.0 Cr 1.6% -3.7% 60% Stock Analytics
CIPLA ₹109,559.0 Cr -2% -4.6% 49.9% Stock Analytics
DIVIS LABORATORIES ₹103,416.0 Cr -0.9% 4.2% 14.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,088.9 Cr -2.1% -0.9% 89.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,939.0 Cr -3.1% -4.7% 21.6% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

-3.3%

9.6%

-3%

SENSEX

-0.6%

-2.1%

18.4%


You may also like the below Video Courses